Zi‐Zhan Li

647 citations
41 papers · 403 indexed · h-index 13
Topics
Head and Neck Cancer Studies (9 papers)Cancer Immunotherapy and Biomarkers (6 papers)Immunotherapy and Immune Responses (4 papers)
Journals
SHILAP Revista de lepidopterologíaScientific ReportsChemical Engineering Journal
Partner nations
ChinaAustraliaCanada

In The Last Decade

Zi‐Zhan Li

34 papers receiving 398 citations

Peers

Zi‐Zhan Li
Comparison fields: 5 of 94
  • Molecular Biology 116
  • Oncology 104
  • Pulmonary and Respiratory Medicine 68
  • Otorhinolaryngology 65
  • Surgery 63
Replace Kenichi Kumagai with:
Kenichi Kumagai Japan
Qingang Hu China
Nian‐Nian Zhong China
Anxun Wang China
Wu‐tong Ju China
Ryota Matsubara Japan
Naomi C. Delic Australia
Elizabeth M. Gillies United States
Elham Alsahafi Saudi Arabia
Zi‐Zhan Li relative to Kenichi Kumagai Japan Kenichi Kumagai's profile →
Citations per field
00.5×10×15×18.8×
Kenichi Kumagai · 1×
Citations per year

Countries citing papers authored by Zi‐Zhan Li

Since Specialization
Citations

This map shows the geographic impact of Zi‐Zhan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi‐Zhan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi‐Zhan Li more than expected).

Fields of papers citing papers by Zi‐Zhan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zi‐Zhan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi‐Zhan Li. The network helps show where Zi‐Zhan Li may publish in the future.

Co-authorship network of co-authors of Zi‐Zhan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zi‐Zhan Li. A scholar is included among the top collaborators of Zi‐Zhan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zi‐Zhan Li. Zi‐Zhan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 1
5 1
6 0
7 3
8 0
9 3
10 14
11 5
12 6
13 4
14 12
15 15
16 11
17 22
18 10
19 4
20 20

About Zi‐Zhan Li

Zi‐Zhan Li is a scholar working on Otorhinolaryngology, Health Informatics and Oncology, having authored 41 papers that have together received 403 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (9 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Otorhinolaryngology (65 citations), Complementary and Manual Therapy (16 citations) and Cancer Research (60 citations). Zi‐Zhan Li has collaborated with scholars based in China, Australia and Canada. Frequent co-authors include Lin‐Lin Bu, Lei‐Ming Cao, Nian‐Nian Zhong, Yao Xiao, Bing Liu, Z. J. Shang, Fang‐Yi Huo, Qiuji Wu, Hanqi Wang and C. F. Xu. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Chemical Engineering Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026